Practical considerations in secondary prevention of CVD - 4th February 2025

This engaging webinar focused on the critical role of pharmacists and pharmacy technicians in secondary prevention of cardiovascular disease (CVD).

Emily Turner, GP Practice Pharmacist and Clinical Lead for CVD Prevention at West Yorkshire ICB, explored the latest evidence, practical tips, and case-based discussions to optimise medical and non-medical therapies and improve patient outcomes.

Learn how to identify gaps in care, implement personalised targets, and utilise non-statin therapies effectively. Gain actionable insights into managing high-risk patients post-acute coronary syndrome, stroke, and critical limb ischemia while supporting medication adherence and lifestyle changes. Equip yourself with the knowledge to make a lasting impact on reducing recurrent CVD events.

This is an essential session for pharmacy professionals committed to advancing their role in cardiovascular health and secondary prevention strategies.

Emily Turner is the Lead GP Practice Pharmacist for a large practice in Leeds, with a special interest in cardio-renal disease. She also serves as the West Yorkshire Clinical Lead for CVD Prevention, working across the West Yorkshire Health and Care Partnership to improve cardiovascular outcomes. Emily contributes nationally as a member of the England CVDPREVENT Audit Clinical Panel, the National AF Expert Advisory Group, and as a Clinical Educator for the Royal Pharmaceutical Society. A highly experienced speaker, Emily brings a wealth of expertise and practical advice to this webinar, making it an unmissable opportunity for pharmacy professionals.

Practice Plus monthly webinar - 4th February 2025 - Presentation.pdf

Figure 4. (A) Treatment algorithm for pharmacological low-density lipoprotein cholesterol lowering. (B) Treatment goals.pdf

(To enlarge the video click on the stretch icon on the bottom right of the video).